Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Mouse
61%
IC50
57%
Histone Deacetylase Inhibitor
41%
Disease
37%
Pharmacokinetics
37%
Neoplasm
37%
Cytotoxicity
36%
Anticarcinogen
32%
Cohort Study
30%
Histone Deacetylase
29%
Antioxidant
28%
Lipopolysaccharide
26%
Tubulin
25%
Colorectal Cancer
23%
Anti-Inflammatory Drug
21%
Histone Deacetylase 6
21%
High Performance Liquid Chromatography
21%
Hydroxamic Acid
21%
Breast Cancer
20%
Non Small Cell Lung Cancer
19%
Cyclooxygenase 2
18%
Nitric Oxide
18%
Reactive Oxygen Metabolite
18%
Inflammation
18%
Lung Cancer
18%
Bioavailability
17%
Western Blot
16%
Micelle
16%
Antiproliferative Activity
16%
Tumor Growth
15%
Drug Delivery System
15%
Antitumor Activity
15%
Diabetes Mellitus
15%
Colon Cancer
15%
Protein P53
15%
Resveratrol
15%
Inducible Nitric Oxide Synthase
14%
Mouse Model
14%
Xanthine Oxidase
14%
Macrogol
13%
Vorinostat
13%
Caspase 3
13%
Calcium Ion
13%
Liver Cell Carcinoma
13%
Traditional Chinese Medicine
12%
Cytokine
12%
Nanoparticle
12%
Injury
12%
Epidermal Growth Factor Receptor
12%
Antioxidant Capacity
12%
Tablet
12%
Prostate Cancer
12%
Flavonoid
11%
Cisplatin
11%
Antiinflammatory Activity
11%
Nephrotoxicity
11%
Drug Release
11%
Methylglyoxal
11%
Combination Therapy
10%
Virtual Screening
10%
Glioblastoma
10%
Aristolochic Acid
10%
Phosphotransferase
10%
Structure Activity Relationship
10%
Gelatinase B
9%
Histone Deacetylase 1
9%
Doxorubicin
9%
Lactic Acid
9%
Alzheimer's Disease
9%
Chitosan
9%
Nuclear Factor
9%
Prevalence
9%
Chemotherapy
9%
Biological Marker
9%
Tannin Derivative
9%
Free Radical
9%
Biological Activity
9%
Cytotoxicity
9%
Tumor Necrosis Factor
8%
Hyperlipidemia
8%
Leukemia
8%
Gene Delivery
8%
Indole
8%
Ethanol
8%
Caffeic Acid
8%
Metformin
8%
Wound Healing
8%
Quercetin
8%
Clinical Trial
8%
Nanocarrier
7%
Non Insulin Dependent Diabetes Mellitus
7%
Alternative Complement Pathway C3 C5 Convertase
7%
Cantharidin
7%
Rat Model
7%
Docetaxel
7%
Normal Human
7%
Egg Lecithin
7%
Streptozotocin
7%
Indometacin
7%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
49%
Histone Deacetylase
22%
Mouse
19%
Dynamics
16%
Single-Nucleotide Polymorphism
16%
Anticancer
15%
Cohort Study
12%
Cell Migration
12%
Gene Expression
12%
Signal Transduction
12%
Colon
11%
Messenger RNA
11%
Cell Proliferation
10%
IC50
10%
P53
10%
Proteomics
9%
Autophagy
9%
Cytotoxicity
9%
Cell Death
9%
HDAC6
8%
Amyloid
7%
down Regulation
7%
Enzyme
7%
Oxidative Stress
7%
Western Blot
7%
Genetic Divergence
7%
Tumor Progression
7%
Genetics
7%
Pharmacokinetics
7%
Antineoplastic Activity
7%
Cell Growth
6%
Metabolite
6%
Genotyping
6%
Eicosanoid Receptor
6%
Cyclooxygenase
6%
Epidermal Growth Factor Receptor
6%
Genetic Polymorphism
6%
ORAI1
6%
Protein Expression
5%
Allele
5%
Genome-Wide Association Study
5%
Promoter Region
5%
Resveratrol
5%
Upregulation
5%
Mass Spectrometry
5%
Hypoxia Inducible Factor 1
5%
Aryl Hydrocarbon Receptor
5%
Medicine and Dentistry
In Vitro
28%
Cancer Cell
25%
Programmed Cell Death
22%
Malignant Neoplasm
14%
Disease
13%
Histone Deacetylase
13%
Cohort Analysis
11%
IC50
10%
Breast Cancer
10%
Cytotoxicity
10%
Histone Deacetylase Inhibitor
10%
Antioxidant
9%
Signal Transduction
9%
Autophagy
9%
Colorectal Cancer
9%
Reactive Oxygen Species
8%
Drug Therapy
8%
Neoplasm
8%
Gene Expression
8%
Medicine
8%
Cell Proliferation
7%
Metastatic Carcinoma
7%
Antineoplastic Activity
7%
Tumor Progression
7%
Anti-Inflammatory Drug
7%
Kawasaki Disease
6%
Hazard Ratio
6%
Cyclooxygenase 2
6%
Lung Cancer
6%
Diabetes Mellitus
6%
Calcium Ion
6%
Anticarcinogen
6%
Traditional Chinese Medicine
6%
Non Small Cell Lung Cancer
6%
Glycon
6%
Cell Death
6%
Cancer Therapy
6%
Maturity Onset Diabetes of the Young
6%
4 Iodo 2,5 Dimethoxyamphetamine
6%
Glioblastoma
5%
Tubulin
5%
Prostate Cancer
5%
Supplementation
5%
Cell Migration
5%
HDAC1
5%
Health Care Cost
5%
Histone Deacetylase 6
5%
Xenograft
5%
Patient with Type 2 Diabetes
5%
Biological Marker
5%
Cancer Growth
5%
Diabetes
5%
Protein P53
5%
Oxidative Stress
5%
Retrospective Cohort Study
5%